600 MADISON AVENUE, SUITE 1601, NEW YORK, NY
Investor Presentation
iBio, Inc. Enters Open Market Sale Agreement with Jefferies LLC
Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update
$26 Million Private Placement
Annual Meeting of Stockholders - Director Elections Held on November 20, 2025
News
Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update
Other Events
Q2
Amended Quarterly Report
Q1
FY 2025
Q3
Amended Annual Report
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(3)
Notice of Exempt Offering of Securities
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Correspondence
Submission Upload